10 Best Building Product Stocks To Buy For 2014

It's been a volatile year for the roofing industry, and over the last three months, investors have seen more downside. Roofing materials distributor Beacon Roofing Supply (NASDAQ: BECN  ) is down 11.5% in the last three months, and building products manufacturer Owens Corning (NYSE: OC  ) fell 5.5% in the same period -- all in a year when many commentators thought this sector would outperform.�

It's complicated
A resurgent housing market should lead to a marginal increase in new residential roofing demand, while the underlying reroofing demand should provide its usual support. Indeed, these conditions looked like they were in place for 2013, and analysts built a fair amount of optimism into their expectations. So what went wrong?

First, the US has had some unusual weather patterns in recent years. In previous years, hurricane Irene (and to a lesser extent Sandy) helped to generate reroofing demand, while this year's weather has been far more clement. Worse yet, according to Owens Corning, those storms pulled forward reroofing work that homeowners might otherwise have planned to do this year. And this spring's bout of wet weather further hurt roofing activity, because contractors simply couldn't work.

Top 5 Sliver Companies To Invest In Right Now: Kamada Ltd (KMDA)

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company�� product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other. Advisors' Opinion:

• [By Life Sciences Report]

  AF: Kamada Ltd. (KMDA) is a relatively unknown Israeli company that is doing very well. It is listed on the Tel Aviv Stock Exchange and the NASDAQ. It has an intravenous form of a drug for alpha-1 antitrypsin (AAT) deficiency, which causes lung and liver disease, that is partnered with Baxter International Inc. (BAX).

• [By Jake L'Ecuyer]

  Equities Trading UP
  Kamada (NASDAQ: KMDA) shares shot up 2.64 percent to $15.37 after the company announced the US proof-of-concept study with Glassia to treat GVHD.

• [By Monica Gerson]

  Kamada (NASDAQ: KMDA) shares fell 27.54% to $10.00 in pre-market trading after the company reported preliminary Alpha-1 Antitrypsin Phase II/III trial results.

10 Best Building Product Stocks To Buy For 2014: Turkiye Garanti Bankasi AS (GARAN)

Turkiye Garanti Bankasi AS (the Bank) is a Turkey-based financial services company. The Bank provides retail, commercial, corporate and small and medium size enterprises (SME) banking, leasing, insurance, asset management and factoring services. Other operation heading under the banking segment include mainly treasury and investment banking activities as well as unallocated income and expense items. It has a network of 822 domestic branches, seven foreign branches, three representative offices abroad and 104 offices. In addition to its branches, the Bank has 100% ownership in three banks each of which is located in Amsterdam, Bucharest and Moscow. The Bank and its affiliates operate principally in Turkey, but also have operations in the Netherlands, Romania, Russia, Turkish Republic of Northern Cyprus, Malta, Luxembourg and Germany. Advisors' Opinion:

• [By Ian Sayson]

  Russia�� Micex Index declined, trimming its weekly gain to 2.5 percent. OAO Mechel, the nation�� biggest producer of coal for steelmakers, slumped 1.7 percent. The Borsa Istanbul National 100 Index sank 2 percent as Turkiye Garanti Bankasi AS (GARAN) led losses in lenders. Benchmark gauges in the Czech Republic and Hungary declined at least 1.2 percent.

• [By Halia Pavliva]

  Turkiye Garanti (GARAN) Bankasi AS, the largest Turkish lender by market value, led gains on the Borsa Istanbul National 100 Index, which rose 1.5 percent. Garanti climbed 1.3 percent after slumping 4.1 percent to the lowest level since Sept. 13 yesterday. The government is selling $1.25 billion of five-year Islamic bonds today, according to a person with direct knowledge of the transaction, who asked not to be identified because the information is private.

10 Best Building Product Stocks To Buy For 2014: Tyson Foods Inc.(TSN)

Tyson Foods, Inc., together with its subsidiaries, engages in the production, distribution, and marketing of chicken, beef, pork, and prepared food products, as well as related allied products worldwide. The company?s Chicken segment involves in breeding and raising chickens, as well as processing live chickens into fresh, frozen, and value-added chicken products. Its Beef segment processes live fed cattle and fabricates dressed beef carcasses into primal and sub-primal meat cuts and case-ready products The company?s Pork segment involves in the processing live market hogs; and fabricating pork carcasses into primal and sub-primal cuts and case-ready products. Its Prepared Foods segment manufactures and markets frozen and refrigerated food products comprising pepperoni, bacon, beef and pork pizza toppings, pizza crusts, flour and corn tortilla products, appetizers, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, and processed meats. The company mark ets and sells its products to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, international export companies, and domestic distributors, as well as to foodservice operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors. Tyson Foods, Inc. also offers its allied products to the manufacturers of pharmaceuticals and technical products, as well as to pork processors. The company was founded in 1935 and is headquartered in Springdale, Arkansas.

Advisors' Opinion:

• [By Arturo Cuevas]

  It looks like you and I will be eating more chicken this 2014. Retail beef prices remain at record highs, and we consumers will likely be driven more toward comparatively cheaper chicken meat in 2014. Given this trend, loading up on shares of Sanderson Farms (NASDAQ: SAFM  ) , Pilgrim's Pride (NASDAQ: PPC  ) , and�Tyson Foods (NYSE: TSN  ) �should be worth considering.

• [By Laura Brodbeck]

  Next week investors will be waiting for several key earnings reports including Tyson Foods, Inc. (NYSE: TSN), Walt Disney Company (NYSE: DIS), Pfizer, Inc. (NYSE: PFE) �and DIRECTV (NASDAQ: DTV).

• [By Sue Chang and Saumya Vaishampayan]

  Tyson Foods Inc. (TSN) �shares added 4.4%. The meat company on Monday reported fiscal fourth-quarter profit of $261 million, or 70 cents a share, on $8.9 billion in sales. Adjusted earnings increased to 70 cents. Analysts polled by FactSet had expected earnings of 69 cents a share on sales of $8.8 billion.

10 Best Building Product Stocks To Buy For 2014: Obagi Medical Products Inc.(OMPI)

Obagi Medical Products, Inc., a specialty pharmaceutical company, develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems. It offers Obagi Nu-Derm System, including prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems that are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System comprises Vitamin C with 4% hydroquinone system to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Professional-C products consisting of Vitamin C serums for the treatment of antioxidant protection, fine lines, wrinkles, and hyperpigmentation. The company also provides ELASTIderm Eye and D�olletage, which increases the elasticity and skin tone of eyes, face, neckline, and chest; ELASTILash Eyelash Solution that enhances the appearance of thickness and fullness of eyelashes; CLENZIderm M.D. Systems and Tretinoin for treating acne; and Obagi Rosaclear System used for the treatment of rosacea. In addition, it offers Refissa and Blue Peel RADIANCE used for the treatment of fine facial lines, hyperpigmentation, and tactile roughness; Metronidazole used for the treatment of rosacea; Obagi Blue Peel Essential Kit used for the treatment of fine lines, wrinkles, and hyperpigmentation. Further, the company licenses non-prescription product concepts under the Obagi trademark to a Japanese-based pharmaceutical company for sale through consumer distribution channels in Japan. Obagi Medical Products, Inc. sells its products through sales force and distribution partners in the United States, North and Central America, Europe, the Middle East, and Asia to dermatologists, plastic surgeons, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Lon g Beach, California.

Advisors' Opinion:

• [By David Williamson]

  Though many excited traders had hoped to see the bidding war continue between Valeant Pharmaceuticals (NYSE: VRX  ) and Merz over Obagi Medical Products (NASDAQ: OMPI  ) and a subsequent run-up in the stock price of the smaller dermatological products maker, Merz has now walked away from the table, leaving the highly acquisitive Valeant the victor. In this video, Motley Fool health care analyst David Williamson gives us some background on these companies and tells us how Valeant plans to profit from the deal, and describes for investors why this is a win both for Obagi and for Valeant.

10 Best Building Product Stocks To Buy For 2014: Powershares High Yield Equity Dividend (PEY)

PowerShares High Yield Equity Dividend Achievers Portfolio is based on the Mergent Dividend Achievers 50 Index. The Mergent Dividend Achievers 50 Index seeks to deliver current income and capital appreciation. It comprises the fifty highest yielding companies with at least 10 years of consecutive dividend increases.

The Index�� high dividend yield approach provides exposure to deep value companies while the long-term dividend growth requirement attempts to minimize exposure to distressed value companies. The yield weighted portfolio is rebalanced quarterly and reconstituted annually.

Advisors' Opinion:

• [By Chuck Saletta]

  PowerShares High Yield Dividend Achievers (NYSEMKT: PEY  )

  50 higher yielding members of the dividend achievers index�

• [By Chuck Saletta]

  If that savings target seems too high, your options include either working longer (to keep the length of your retirement shorter) or investing more aggressively. For instance, the PowerShares High Yield Dividend Achievers (NYSEMKT: PEY  ) invests in higher-yielding companies with decent histories of raising their payouts. That ETF currently yields more than the Vanguard bond fund, and the companies in the PowerShares ETF have the potential to raise their payouts as they grow.

10 Best Building Product Stocks To Buy For 2014: Healthways Inc.(HWAY)

Healthways, Inc., through its subsidiaries, provides specialized, comprehensive solutions to assist people to maintain and enhance their health and well-being. The company?s evidence-based programs provide specific and personalized interventions for each individual in a population, irrespective of age, or health status; and delivers to consumers by phone, mail, Internet, and face-to-face interactions. It also offers wellness and disease prevention solutions through total population screening, well-being assessments, and supportive interventions; access to health improvement programs, such as fitness solutions, weight management, chiropractic, and complementary and alternative medicine; and educational materials and personal interactions with trained nurses and other healthcare professionals to create and sustain healthier behaviors for individuals who are in the early stages of chronic conditions. In addition, the company operates care enhancement and coaching centers; fi tness centers; and provides health improvement programs and services in Brazil, Australia, and France. Healthways, Inc. delivers its programs to various customers, including health plans, employers, integrated healthcare systems, hospitals, physicians, and government entities in the United States, the District of Columbia, and Puerto Rico. The company was founded in 1981 and is headquartered in Franklin, Tennessee.

Advisors' Opinion:

• [By Lauren Pollock]

  Healthways Inc.'s(HWAY) profit fell 64%, hurt by shrinking margins and flat revenue. Shares of Healthways fell as the company lowered its guidance for the year, while issuing downbeat estimates for the fourth quarter and 2014.

• [By Holly LaFon]

  The last company I want to mention is HealthWays (HWAY), which was once a small-cap growth stock favorite. Due to increasing changes in the U.S. healthcare industry, as well as confusion around the implementation of ObamaCare, the company recently expanded its business to not just physical wellness but to social and emotional wellness, health, and nutrition.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Healthways (Nasdaq: HWAY  ) , whose recent revenue and earnings are plotted below.

10 Best Building Product Stocks To Buy For 2014: Nestle SA (NESN)

Nestle SA is a Swiss Company engaged in the nutrition, health and wellness sectors. It is the holding company of the Nestle Group, which comprises subsidiaries, associated companies and joint ventures throughout the world. It has such business units as Food and Beverage, Nestle Waters and Nestle Nutrition. It is also active in the pharmaceutical sector. It divides its products into Powdered and liquid beverages, Water, Milk products and Ice cream, Nutrition, Prepared dishes and cooking aids, Confectionery, PetCare and Pharmaceutical products. In February 2011, the Company acquired CM&D Pharma Ltd. Advisors' Opinion:

• [By Corinne Gretler]

  Swiss stocks fell for a second day, their first back-to-back losses this month, as Nestle (NESN) SA retreated after reporting slower growth in sales.

• [By Chad Fraser]

  These are the first significant moves made by the Caira, a former executive at Nestle SA (NYSE: NESN) who helped expand that company’s hot and cold beverage division.

• [By Celeste Perri]

  Nestle SA (NESN) is selling Givaudan (GIVN) SA shares worth $1.27 billion at yesterday�� closing price to institutional investors, winding down its stake in the world�� largest flavorings maker.